Skip to content

Randomised trial of vitamin D and calcium for the secondary prevention of osteoporosis related fractures in the elderly

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN51647438
Enrollment
5250
Registered
2000-10-23
Start date
1998-11-18
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary care Musculoskeletal Diseases Osteoporosis with pathological fracture

Interventions

Daily oral Vitamin D/Calcium/Vitamin D and calcium in combination/placebo

Sponsors

Medical Research Council (MRC) (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 70 years or over (irrespective of sex) 2. Recent first proximal femoral or other appendicular fracture sustained in a fall or clinical vertebral fracture 3. Attending fracture clinic or hospital in-patient 4. Resident in UK 5. Able to comply with protocol (eg Mini-mental Score greater than 7) 6. Gives consent

Exclusion criteria

Exclusion criteria: 1. Multiple or high energy transfer injury 2. Inability to walk prior to presenting fracture without the support of others 3. Suffering from known malignant disease 4. Contraindication to Calcium or Vitamin D 5. Current or recent treatment with more than 200iu daily of Vitamin D, Calcium, Fluoride, Diphosphonate or Calcitonin

Design outcomes

Primary

MeasureTime frame
1. New fractures, 2. Cost per avoided new fracture 3. Quality of life gain

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 21, 2026